4.7 Article

Preparation, cytotoxicity, and in vivo antitumor efficacy of 111In-labeled modular nanotransporters

Journal

INTERNATIONAL JOURNAL OF NANOMEDICINE
Volume 12, Issue -, Pages 395-410

Publisher

DOVE MEDICAL PRESS LTD
DOI: 10.2147/IJN.S125359

Keywords

nuclear delivery; cancer; melanoma; radionuclide therapy; Auger electrons

Funding

  1. Russian Science Foundation [14-14-00874]
  2. [0100-2014-0013]
  3. [13411.1008799.13.135]
  4. Russian Science Foundation [14-14-00874] Funding Source: Russian Science Foundation

Ask authors/readers for more resources

Purpose: Modular nanotransporters (MNTs) are a polyfunctional platform designed to achieve receptor-specific delivery of short-range therapeutics into the cell nucleus by receptor-mediated endocytosis, endosome escape, and targeted nuclear transport. This study evaluated the potential utility of the MNT platform in tandem with Auger electron emitting In-111 for cancer therapy. Methods: Three MNTs developed to target either melanocortin receptor-1 (MC1R), folate receptor (FR), or epidermal growth factor receptor (EGFR) that are overexpressed on cancer cells were modified with p-SCN-Bn-NOTA and then labeled with In-111 in high specific activity. Cytotoxicity of the In-111-labeled MNTs was evaluated on cancer cell lines bearing the appropriate receptor target (FR: HeLa, SK-OV-3; EGFR: A431, U87MG. wtEGFR; and MC1R: B16-F1). In vivo micro-single-photon emission computed tomography/computed tomography imaging and antitumor efficacy studies were performed with intratumoral injection of MC1R-targeted In-111-labeled MNT in B16-F1 melanoma tumor-bearing mice. Results: The three NOTA-MNT conjugates were labeled with a specific activity of 2.7 GBq/mg with nearly 100% yield, allowing use without subsequent purification. The cytotoxicity of In-111 delivered by these MNTs was greatly enhanced on receptor-expressing cancer cells compared with In-111 nontargeted control. In mice with B16-F1 tumors, prolonged retention of I-111(n) by serial imaging and significant tumor growth delay (82% growth inhibition) were found. Conclusion: The specific in vitro cytotoxicity, prolonged tumor retention, and therapeutic efficacy of MC1R-targeted In-111-NOTA-MNT suggest that this Auger electron emitting conjugate warrants further evaluation as a locally delivered radiotherapeutic, such as for ocular melanoma brachytherapy. Moreover, the high cytotoxicity observed with FR- and EGFR-argeted In-111-NOTA-MNT suggests further applications of the MNT delivery strategy should be explored.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biology

Exploiting active nuclear import for efficient delivery of Auger electron emitters into the cell nucleus

Andrey A. Rosenkranz, Tatiana A. Slastnikova, Mikhail O. Durymanov, Georgii P. Georgiev, Alexander S. Sobolev

Summary: This review discusses the development of effective anticancer agents for delivering AE emitters into the nuclei of target cancer cells. The use of peptide-based conjugates, nanoparticles, recombinant proteins, and other constructs for targeted intranuclear delivery of AE emitters, as well as their advantages and limitations, are discussed.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2023)

Review Medicine, Research & Experimental

Nrf2/Keap1/ARE signaling: Towards specific regulation

Alexey Ulasov, Andrey A. Rosenkranz, Georgii P. Georgiev, Alexander S. Sobolev

Summary: The Nrf2 transcription factor regulates the expression of genes involved in cell defense against oxidative stress, which is associated with various diseases. The interactions between Nrf2 and Keap1 protein play a crucial role in this regulation. The activation of the Nrf2 system is considered as a promising strategy to treat diseases related to oxidative stress, including COVID-19. Two approaches are being developed to inactivate the Keap1 guardian function and enhance Nrf2 activity.

LIFE SCIENCES (2022)

Article Pharmacology & Pharmacy

An Approach to Evaluate the Effective Cytoplasmic Concentration of Bioactive Agents Interacting with a Selected Intracellular Target Protein

Yuri V. Khramtsov, Alexey V. Ulasov, Andrey A. Rosenkranz, Tatiana A. Slastnikova, Tatiana N. Lupanova, Georgii P. Georgiev, Alexander S. Sobolev

Summary: To compare the effectiveness of bioactive agents in cells, it is important to assess their effective concentrations. This work proposes a method to evaluate the effective concentrations of bioactive agents and target proteins based on a simple equilibrium model and the CETSA. The method was tested by analyzing the concentrations of Nrf2 and Keap1 proteins in different cell lines and comparing them with literature data. This approach allows for the analysis of protein-protein or molecule-protein interactions in the cell and can be useful in studying drug delivery systems.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Mouse Syngeneic Melanoma Model with Human Epidermal Growth Factor Receptor Expression

Tatiana A. Slastnikova, Andrey A. Rosenkranz, Alexey V. Ulasov, Yuri V. Khramtsov, Tatiana N. Lupanova, Georgii P. Georgiev, Alexander S. Sobolev

Summary: In this study, we developed a mouse syngeneic melanoma model with preserved in vivo expression of human EGFR and tested its functionality. This model has important applications for high-throughput in vivo screening of EGFR-targeting agents.

PHARMACEUTICS (2022)

Article Biochemistry & Molecular Biology

Intracellular Delivery of an Antibody-Like Molecule Capable of Inhibiting c-Myc

T. N. Lupanova, A. V. Ulasov, Y. V. Khramtsov, A. A. Rozenkranz, G. P. Georgiev, A. S. Sobolev

Summary: A modular nanotransporter (MNT) carrying an antibody-like molecule, anti-c-Myc nanobody, was synthesized and characterized. It was found that the MNT could bind to the target protein, c-Myc oncogene, with a dissociation constant of 46 +/- 14 nM. Moreover, the MNT was able to internalize into target cells, alter Myc-dependent expression, and exhibit antiproliferative effects.

DOKLADY BIOCHEMISTRY AND BIOPHYSICS (2023)

Review Pharmacology & Pharmacy

Prospects of Using Protein Engineering for Selective Drug Delivery into a Specific Compartment of Target Cells

Andrey A. Rosenkranz, Tatiana A. Slastnikova

Summary: A large variety of proteins have been used successfully for the treatment of different diseases, especially cancer. While most drugs target cell surface proteins, the majority of therapeutic targets are actually located inside the cell. Traditional low molecular weight drugs can penetrate all cells, causing side effects. Recent studies focus on designing multifunctional proteins to overcome these challenges and deliver drugs to the desired intracellular compartment of target cells. This review discusses the application of artificial constructs for targeted delivery of protein-based and low molecular weight drugs, as well as the obstacles and means to overcome them.

PHARMACEUTICS (2023)

Article Optics

Local Field Enhancement Due to the Edge States of Nanoplasmonic Crystal

Behrokh Beiranvand, Rustam A. Khabibullin, Alexander S. Sobolev

Summary: In this paper, the authors investigate the enhancement of local electric fields in a nanoplasmonic crystal due to the existence of photonic edge states. They demonstrate that these states can be excited by incident waves and are localized along line defects in the crystal. Numerical simulations show a 12-fold enhancement of the electric field for incident plane waves at a wavelength of 545 nm. This effect can be utilized to improve the sensitivity of SERS spectroscopy, increase the Purcell factor of quantum systems, and enhance higher harmonic generation.

PHOTONICS (2023)

Review Pharmacology & Pharmacy

DNA Repair Inhibitors: Potential Targets and Partners for Targeted Radionuclide Therapy

Honoka Obata, Mikako Ogawa, Michael R. Zalutsky

Summary: The present review explores potential targets/partners for future targeted radionuclide therapy (TRT) strategies. It discusses key factors in the cancer genome, such as DNA damage response/repair and maintenance systems, that contribute to the survival of cancer cells despite receiving high radiation doses. The review suggests targeting DNA maintenance factors as a promising strategy to enhance the effectiveness of TRT, considering their cancer-specific abilities and dysregulated systems.

PHARMACEUTICS (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose 211At-Labeled Anti-HER2 Single-Domain Antibody Fragment

Yutian Feng, Rebecca Meshaw, Xiao-Guang Zhao, Stephen Jannetti, Ganesan Vaidyanathan, Michael R. Zalutsky

Summary: This study evaluates the therapeutic potential of single-domain antibody fragments (sdAbs) combined with alpha-particle therapy for HER2-expressing cancers. The results demonstrate that HER2-specific sdAbs, such as 5F7 and VHH_1028, show better efficacy in tumor growth inhibition compared to HER2-irrelevant VHH_2001, suggesting that combining high-affinity HER2-targeted sdAbs with a residualizing prosthetic agent is a promising strategy for targeted alpha-particle therapy.

JOURNAL OF NUCLEAR MEDICINE (2023)

Article Oncology

Low-level whole-brain radiation enhances theranostic potential of single-domain antibody fragments for human epidermal growth factor receptor type 2 (HER2)-positive brain metastases

Daniele Procissi, Stephen A. Jannetti, Markella Zannikou, Zhengyuan Zhou, Darryl McDougald, Deepak Kanojia, Hui Zhang, Kirsten Burdett, Ganesan Vaidyanathan, Michael R. Zalutsky, Irina Balyasnikova

Summary: Low-level brain irradiation induces dynamic changes in tumor vasculature, which increase the delivery of anti-HER2 VHH to intracranial tumors. This finding could facilitate the detection, monitoring, and treatment of HER2-expressing brain metastases.

NEURO-ONCOLOGY ADVANCES (2022)

No Data Available